PPIL3 and hepatocellular carcinoma: Importantly, we demonstrated that CyPJ is frequently upregulated in a small cohort of hepatocellular carcinoma (HCC), and CyPJ-based targeting leads to tumor suppression of HCC in a xenograft mouse tumor model (Chen et al., 2015).